Skip to main content

Advertisement

Log in

A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis

Osteoporosis International Aims and scope Submit manuscript

Abstract:

The aim of the study was to review the effect of etidronate on bone density and fractures in postmenopausal women. We searched MEDLINE from 1966 to 1998, examined citations of relevant articles, and the proceedings of international osteoporosis meetings. We contacted osteoporosis investigators to identify additional studies, primary authors, and pharmaceutical industry sources for unpublished data. We included 13 trials that randomized women to etidronate or an alternative (placebo or calcium and/or vitamin D) and measured bone density for at least 1 year. For each trial, three independent reviewers assessed the methodologic quality and abstracted data. The data suggested a reduction in vertebral fractures with a pooled relative risk of 0.63 (95% CI 0.44 to 0.92). There was no effect on nonvertebral fractures (relative risk 0.99, (95% CI 0.69 to 1.42). Etidronate, relative to control, increased bone density after 1–3 years of treatment in the lumbar spine by 4.06% (95% CI 3.12 to 5.00), in the femoral neck by 2.35% (95% CI 1.66 to 3.04) and in the total body by 0.97% (95% CI 0.39 to 1.55). Effects were larger at 4 years, though the number of patients followed much smaller. Etidronate increases bone density in the lumbar spine and femoral neck for up to 4 years. The pooled estimates of fracture reduction with etidronate suggest a reduction in vertebral fractures, but no effect on nonvertebral fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Consortia

Additional information

Received: 25 February 2000 / Accepted: 8 August 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cranney, A., Guyatt, G., Krolicki, N. et al. A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis . Osteoporos Int 12, 140–151 (2001). https://doi.org/10.1007/s001980170147

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001980170147

Navigation